NCT04370652View on ClinicalTrials.gov

Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum

CompletedOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2019

Study Completion Date

December 30, 2019

Conditions
Peyronie Disease
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04370652 - Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum | Biotech Hunter | Biotech Hunter